The Opportunity: Making Cancer Treatment Safer and More Efficient | Radiation therapy is used to treat millions of cancer patients…
Read More about MONIQA™: Automated Quality Assurance for Radiation TherapyThe Opportunity: Reducing IV Medication Errors and Infection Risk | Intravenous medication administration is essential to modern healthcare, yet frequent…
Read More about Multi-Dose IV Delivery PlatformThe Opportunity: Unlocking Previously “Undruggable” Diseases | Protein-protein interactions (PPIs) drive many of the biological pathways involved in cancer, autoimmune…
Read More about AI-Enabled Drug Discovery PlatformProgram: Medical College of Wisconsin
Technology Sectors: Health & Bio, Medical Devices & Imaging
The Opportunity: Making Cancer Treatment Safer and More Efficient | Radiation therapy is used to treat millions of cancer patients each year and requires precise coordination between treatment planning, data transfer, and treatment delivery. While errors are rare, they do occur and can have serious consequences. Safe treatment depends on many quality checks to create
Program: Medical College of Wisconsin
Technology Sectors: Health & Bio
The Opportunity: Safer Blood Circuits for Life-Support and Dialysis Systems | Extracorporeal medical systems such as ECMO, dialysis, and cardiopulmonary bypass rely on tubing circuits that move blood outside the body for treatment. Connection points within these circuits can create disruptions in blood flow that increase the risk of clot formation, blood cell damage, and
Program: UWM Research Foundation
Technology Sectors: Health & Bio, Medical Devices & Imaging
The Opportunity: Reducing IV Medication Errors and Infection Risk | Intravenous medication administration is essential to modern healthcare, yet frequent IV-line access creates opportunities for medication errors, contamination, and bloodstream infections. Current practice often requires multiple syringes, repeated line manipulations, and complex workflows that increase risk in emergency, critical care, and other high-pressure clinical settings.
Program: UWM Research Foundation
Technology Sectors: AI & Data Science, Health & Bio
The Opportunity: Unlocking Previously “Undruggable” Diseases | Protein-protein interactions (PPIs) drive many of the biological pathways involved in cancer, autoimmune disorders, and other serious diseases. Yet many PPIs remain difficult to target because of their complexity and dynamic behavior. As pharmaceutical companies increasingly invest in AI-enabled drug discovery, there is growing demand for platforms that
Program: UWM Research Foundation
Technology Sectors: Health & Bio
The Opportunity: Addressing a Critical Preparedness Gap | Chlorine is one of the most widely used industrial chemicals in the world and is a leading cause of toxic inhalation exposure. Accidental releases, transportation incidents, industrial accidents, and intentional misuse can result in serious lung injury, respiratory distress, and death. Despite the ongoing risk, there is
Program: Medical College of Wisconsin
Technology Sectors: Health & Bio, Medical Devices & Imaging
A truer picture of radiation dose for individualized cancer care As patients change during treatment, this innovation enables radiation dose assessment to change with them. By moving beyond static assumptions, it supports more accurate insight into how therapy affects tumors and healthy tissue—helping advance truly adaptive cancer treatment.
Program: Medical College of Wisconsin
Technology Sectors: Medical Devices & Imaging
Making MRI‑guided care clearer, faster, and safer By giving clinicians GPS‑like visual cues inside the MRI, this technology points toward a new standard for image‑guided care—where procedures are more precise, take less time, and place less burden on both patients and clinical teams.
Program: UWM Research Foundation
Technology Sectors: Industrial Technologies
Improving corrosion resistance and safety in critical metal components This technology enables foundries to produce safer, more durable copper and brass components by selectively upgrading surface performance. It improves corrosion resistance and reduces lead leaching using existing foundry processes—delivering higher‑quality products without changing bulk alloys or investing in new equipment.
Program: Medical College of Wisconsin
Technology Sectors: Health & Bio
Longer‑term protection for people and pets at risk As Lyme risk continues to expand, this innovation points toward a new generation of vaccines designed for durability—not short‑lived immunity. The approach aims to provide broader, longer‑term protection for both people and pets in regions where Lyme disease is becoming a persistent and growing threat.
Program: Versiti
Technology Sectors: Health & Bio
Addressing the heart‑disease risk that today’s drugs leave behind Even with medication, millions remain at risk for cardiovascular events. This innovation points toward a new class of therapies that address the full range of harmful blood lipoproteins—opening more complete and durable protection for patients underserved by today’s standard treatments.
